IVBT (Innovation1 Biotech) Other Current Receivables: $0.00 Mil (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Other Current Receivables?

Innovation1 Biotech IVBT 12 Other Current Receivables is $0.00 Mil as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's Other Current Receivables for the quarter that ended in Feb. 2024 was $0.00 Mil.

Innovation1 Biotech's quarterly Other Current Receivables declined from Aug. 2023 ($0.01 Mil) to Nov. 2023 ($0.00 Mil) but then stayed the same from Nov. 2023 ($0.00 Mil) to Feb. 2024 ($0.00 Mil).

Innovation1 Biotech's annual Other Current Receivables increased from Aug. 2021 ($0.00 Mil) to Aug. 2022 ($0.06 Mil) but then declined from Aug. 2022 ($0.06 Mil) to Aug. 2023 ($0.01 Mil).

Innovation1 Biotech Other Current Receivables Related Terms

Innovation1 Biotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Other Current Receivables Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.06 0.01

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.01 0.00 0.00
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Innovation1 Biotech (IVBT) has a Other Current Receivables of $0.00 Mil as of Feb. 2024. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's Other Current Receivables too high?
Innovation1 Biotech's current Other Current Receivables is $0.00 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Other Current Receivables compare to NVIV and PXMD?
Innovation1 Biotech's Other Current Receivables of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Diversified Financial Services company?
A good Other Current Receivables depends on the Diversified Financial Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Innovation1 Biotech and its competitors. Innovation1 Biotech's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Other Current Receivables is $0.00 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price